NCT04169347 - FOLFOXIRI Plus Panitumumab in Metastatic RAS Wild-type, Left-sided Colorectal Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 2, 2019

Primary Completion Date

December 31, 2024

Study Completion Date

January 31, 2025

Conditions

Colorectal Cancer Metastatic

Interventions

DRUG

Oxaliplatin

2 week cycles

Trial Locations (8)

Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York

Mount Sinai Comprehensive Cancer Center, Miami Beach

University of Iowa Hospitals & Clinics, Iowa City

Kansas University Cancer Center, Westwood

University of Arizona Cancer Center, Tucson

Swedish Cancer Institute, Seattle

Yale Cancer Center, New Haven

Rutgers Cancer Institute of New Jersey, New Brunswick